Shin et al. reported that through simultaneous activation of LETM1 and carboxyl-terminal modulator protein, a synergistic antitumor effect was induced in livers of HCC model mice through the downregulation of the Akt1 pathway [23]. This evidence concerns the gene AKT1 and hepatocellular carcinoma.